Eye viscosity increases with age

Article

According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.

According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.

Dr K. Ishii et al., Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Tokyo, Japan, included 24 eyes of 24 normal human patients in a prospective case series.

The non-contact tonometry procedure was conducted with a high-speed camera. The outcome measures were central corneal thickness (CCT), corneal thickness at 4 mm from the centre, corneal curvature and anterior chamber depth (ACD). IOP was also recorded using Goldmann applanation tonometry (GAT) and dynamic contour tonometer (DCT). The primary outcome measure was energy loss due to elastic hysteresis.

Mean CCT was 552.5 ± 36.1 µm, mean corneal curvature was 7.84 ± 0.26 mm and ACD was 2.83 ± 0.29 mm. Mean GAT-IOP was calculated as 14.2 ± 2.7 mmHg and DCT-IOP was 16.3 ± 3.5 mmHg.

The mean loss of energy due to elastic hysteresis was 3.90 × 10(-6) ± 2.49 × 10(-6) Nm and this was significantly linked to age, regardless of anterior eye structure or IOP.

The abstract for this study can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.